EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10
Medical Devices Regulation - Hazardous Substances
EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020
This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).
Last updated 26 srpnja 2024. Database contains 4917 unique substances/entries.
Filter the list
|
270-687-1
|
68476-47-1
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
Details | |||
|
271-734-9
|
68606-25-7
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
Details | |||
|
270-689-2
|
68476-49-3
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
Details | |||
|
A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100°C (212°F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300°C to 500°C (592°F to 932°F).
|
307-755-8
|
97722-06-0
|
Carc. 1B |
Details | ||
|
A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent-deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300°C to 400°C (572°F to 752°F). It produces a finished oil having a viscosity of 4cSt at approximately 100°C (212°F).
|
307-661-7
|
97675-87-1
|
Carc. 1B |
Details | ||
|
308-132-3
|
97862-82-3
|
Carc. 1B |
Details | |||
|
305-972-2
|
95371-05-4
|
Carc. 1B |
Details | |||
|
A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360°C to 500°C (680°F to 932°F). It produces a finished oil having a viscosity of 4.5cSt at approximately 100°C (212°F).
|
307-662-2
|
97675-88-2
|
Carc. 2 |
Details | ||
|
A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290°C to 350°C (554°F to 662°F). It produces a finished oil having a viscosity of 2cSt at 100°C (212°F).
|
307-659-6
|
97675-85-9
|
Carc. 1B |
Details | ||
|
A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40°C (104°F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250°C to 425°C (482°F to 797°F).
|
307-760-5
|
97722-10-6
|
Carc. 1B |
Details | ||
|
305-971-7
|
95371-04-3
|
Carc. 1B |
Details | |||
|
A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40°C (104°F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240°C to 400°C (464°F to 752°F).
|
307-758-4
|
97722-09-3
|
Carc. 1B |
Details | ||
|
A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230°C to 350°C (446°F to 662°F). It produces a finished oil having a viscosity of 2cSt at 100°C (212°F).
|
307-660-1
|
97675-86-0
|
Carc. 1B |
Details | ||
|
A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 2.2cSt at 40°C (104°F). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200°C to 300°C (392°F to 572°F).
|
307-757-9
|
97722-08-2
|
Carc. 1B |
Details | ||
|
A complex combination of hydrocarbons produced by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164°C to minus 0.5°C (-263°F to 31°F).
|
271-032-2
|
68514-31-8
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
Details | ||
|
A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately -164°C to -0.5°C(-263°F to 31°F).
|
271-038-5
|
68514-36-3
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
Details | ||
|
271-261-8
|
68527-19-5
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
Details | |||
|
A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164°C to minus 42°C (-263°F to -44°F).
|
271-259-7
|
68527-16-2
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
Details | ||
|
A complex combination of hydrocarbons obtained by solvent extraction from a naphthenic distillate having a viscosity of 27cSt at 100°C (212°F). It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C26 through C55 and boiling in the range of approximately 395°C to 640°C (743°F to 1184°F).
|
307-753-7
|
97722-04-8
|
Carc. 1B |
Details | ||
|
The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 210°C (158°F to 410°F).
|
309-749-0
|
100801-66-9
|
Carc. 1B; Muta. 1B |
Details | ||
|
The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70°C to 120°C (158°F to 248°F).
|
309-748-5
|
100801-65-8
|
Carc. 1B; Muta. 1B |
Details | ||
|
The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70°C to 120°C (158°F to 248°F).
|
309-745-9
|
100801-63-6
|
Carc. 1B; Muta. 1B |
Details | ||
|
233-113-0
|
10035-10-6
|
Press. Gas; Skin Corr. 1A; STOT SE 3 |
Details | |||
|
233-113-0
|
10035-10-6
|
Skin Corr. 1B; STOT SE 3 |
Details | |||
|
233-109-9
|
10034-85-2
|
Skin Corr. 1B |
Details | |||
|
233-109-9
|
10034-85-2
|
Press. Gas; Skin Corr. 1A |
Details | |||
|
204-563-5
|
122-66-7
|
Carc. 1B; Acute Tox. 4 |
Details | |||
|
-
|
14913-74-7
|
Expl. 1.1; Self-react. A; Carc. 1B; Acute Tox. 3; Skin Sens. 1 |
Details | |||
|
616-584-0
|
7803-57-8
|
C Carcinogenic (article 57a) |
Details | |||
|
STABO-FIX
|
405-030-1
|
148434-03-1
|
Carc. 1B; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1 |
Details | ||
|
206-114-9
|
302-01-2
|
Flam. Liq. 3; Carc. 1B; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
C Carcinogenic (article 57a) |
Details | ||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
Details | |||
|
-
|
-
|
F Fungi |
Details | |||
|
-
|
-
|
F Fungi |
Details | |||
|
219-698-5
|
2499-95-8
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
Details | |||
|
257-074-4
|
51235-04-2
|
Acute Tox. 4; Eye Irrit. 2 |
Details | |||
|
NATRIUMMETAWOLFRAMAT
|
412-770-9
|
12141-67-2
|
Acute Tox. 4; Eye Dam. 1 |
Details | ||
|
BRUN REACTIF 45; BRUNO REATTIVO 45; C.I. REACTIVE BROWN 45; CIBACROM BROWN 1347; CIBACRON BROWN 1347; REACTIVE BRAUN 45
|
401-650-1
|
85665-96-9
|
Skin Sens. 1 |
Details | ||
|
C.I. BLEU REACTIF 204; C.I. REACTIVE BLUE 204; REACTIVE BLUE 204; REAKTIV BLAU 204
|
400-050-7
|
85153-92-0
|
Resp. Sens. 1; Skin Sens. 1 |
Details | ||
|
RED SF-PE 3534
|
410-180-6
|
157627-99-1
|
Eye Dam. 1 |
Details | ||
|
BRIGHTENER SM 1018 CONC.; LEUCOPHOR BCR
|
405-280-1
|
76508-02-6
|
Eye Irrit. 2 |
Details | ||
|
PROCION EMERALD H-EXL COLOUR; SUBSTANCE S156718
|
417-250-5
|
151436-99-6
|
Eye Dam. 1; Skin Sens. 1 |
Details | ||
|
247-143-7
|
25637-27-8
|
Acute Tox. 4 |
Details | |||